Agilent Technologies Research and Development Expenses 2010-2025 | A
Agilent Technologies annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Agilent Technologies research and development expenses for the quarter ending January 31, 2025 were $113M, a 11.72% decline year-over-year.
- Agilent Technologies research and development expenses for the twelve months ending January 31, 2025 were $464M, a 4.53% decline year-over-year.
- Agilent Technologies annual research and development expenses for 2024 were $0.479B, a 0.42% decline from 2023.
- Agilent Technologies annual research and development expenses for 2023 were $0.481B, a 3% increase from 2022.
- Agilent Technologies annual research and development expenses for 2022 were $0.467B, a 5.9% increase from 2021.
| Agilent Technologies Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $479 |
| 2023 | $481 |
| 2022 | $467 |
| 2021 | $441 |
| 2020 | $495 |
| 2019 | $404 |
| 2018 | $387 |
| 2017 | $341 |
| 2016 | $329 |
| 2015 | $330 |
| 2014 | $358 |
| 2013 | $337 |
| 2012 | $668 |
| 2011 | $649 |
| 2010 | $612 |
| 2009 | $642 |
| Agilent Technologies Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-01-31 | $113 |
| 2024-10-31 | $111 |
| 2024-07-31 | $127 |
| 2024-04-30 | $113 |
| 2024-01-31 | $128 |
| 2023-10-31 | $114 |
| 2023-07-31 | $118 |
| 2023-04-30 | $126 |
| 2023-01-31 | $123 |
| 2022-10-31 | $119 |
| 2022-07-31 | $116 |
| 2022-04-30 | $115 |
| 2022-01-31 | $117 |
| 2021-10-31 | $116 |
| 2021-07-31 | $113 |
| 2021-04-30 | $109 |
| 2021-01-31 | $103 |
| 2020-10-31 | $102 |
| 2020-07-31 | $92 |
| 2020-04-30 | $197 |
| 2020-01-31 | $104 |
| 2019-10-31 | $102 |
| 2019-07-31 | $101 |
| 2019-04-30 | $99 |
| 2019-01-31 | $102 |
| 2018-10-31 | $104 |
| 2018-07-31 | $97 |
| 2018-04-30 | $92 |
| 2018-01-31 | $94 |
| 2017-10-31 | $91 |
| 2017-07-31 | $87 |
| 2017-04-30 | $84 |
| 2017-01-31 | $79 |
| 2016-10-31 | $84 |
| 2016-07-31 | $86 |
| 2016-04-30 | $81 |
| 2016-01-31 | $78 |
| 2015-10-31 | $82 |
| 2015-07-31 | $79 |
| 2015-04-30 | $81 |
| 2015-01-31 | $88 |
| 2014-10-31 | $189 |
| 2014-07-31 | $86 |
| 2014-04-30 | $87 |
| 2014-01-31 | $88 |
| 2013-10-31 | $173 |
| 2013-07-31 | $171 |
| 2013-04-30 | $181 |
| 2013-01-31 | $179 |
| 2012-10-31 | $178 |
| 2012-07-31 | $162 |
| 2012-04-30 | $166 |
| 2012-01-31 | $162 |
| 2011-10-31 | $163 |
| 2011-07-31 | $162 |
| 2011-04-30 | $165 |
| 2011-01-31 | $159 |
| 2010-10-31 | $159 |
| 2010-07-31 | $154 |
| 2010-04-30 | $150 |
| 2010-01-31 | $149 |
| 2009-10-31 | $150 |
| 2009-07-31 | $153 |
| 2009-04-30 | $170 |
| 2009-01-31 | $169 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $30.971B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||